Literature DB >> 18502611

Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.

Judith M Greer1, Michael P Pender.   

Abstract

Myelin proteolipid protein (PLP) is the most abundant protein in central nervous system (CNS) myelin and plays a major role in maintaining the structural and functional integrity of myelin. Its abundance in, and restriction to, CNS myelin and its post-translational modification by acylation make PLP an effective autoantigen, which can induce experimental autoimmune encephalomyelitis in rodents and non-human primates and which is a target of pathogenic autoimmunity in people with multiple sclerosis, a chronic inflammatory demyelinating CNS disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502611     DOI: 10.1016/j.jaut.2008.04.018

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  13 in total

Review 1.  Multiple sclerosis.

Authors:  Alyssa Nylander; David A Hafler
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 2.  The plasticity of human Treg and Th17 cells and its role in autoimmunity.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

3.  Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis.

Authors:  K Mangano; A Nicoletti; F Patti; M Donia; L Malaguarnera; S Signorelli; G Magro; V Muzio; B Greco; P Zaratin; P Meroni; M Zappia; F Nicoletti
Journal:  Clin Exp Immunol       Date:  2009-11-18       Impact factor: 4.330

4.  Aquaporin-4-antibody-positive Neuromyelitis Optica Spectrum Disorder in a Patient with Charcot-Marie-Tooth Disease Type 1A.

Authors:  Yuichi Hamada; Kazusa Takahashi; Takamichi Kanbayashi; Yuki Hatanaka; Shunsuke Kobayashi; Masahiro Sonoo
Journal:  Intern Med       Date:  2020-12-22       Impact factor: 1.271

5.  Homo-β-amino acid containing MBP(85-99) analogs alleviate experimental autoimmune encephalomyelitis.

Authors:  Ravi Kant; Shweta Pasi; Avadhesha Surolia
Journal:  Sci Rep       Date:  2015-02-03       Impact factor: 4.379

Review 6.  Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis.

Authors:  Judith M Greer
Journal:  Mult Scler Int       Date:  2013-11-07

Review 7.  Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes Pathogenesis.

Authors:  Rene J McLaughlin; Matthew P Spindler; Menno van Lummel; Bart O Roep
Journal:  Curr Diab Rep       Date:  2016-07       Impact factor: 4.810

8.  In Silico Perspectives on the Prediction of the PLP's Epitopes involved in Multiple Sclerosis.

Authors:  Zahra Zamanzadeh; Mitra Ataei; Seyed Massood Nabavi; Ghasem Ahangari; Mehdi Sadeghi; Mohammad Hosein Sanati
Journal:  Iran J Biotechnol       Date:  2017-03       Impact factor: 1.671

Review 9.  Effects of Intron 1 Sequences on Human PLP1 Expression: Implications for PLP1-Related Disorders.

Authors:  Patricia A Wight
Journal:  ASN Neuro       Date:  2017 Jul-Aug       Impact factor: 4.146

10.  Isoaspartic acid is present at specific sites in myelin basic protein from multiple sclerosis patients: could this represent a trigger for disease onset?

Authors:  Michael G Friedrich; Sarah E Hancock; Mark J Raftery; Roger J W Truscott
Journal:  Acta Neuropathol Commun       Date:  2016-08-12       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.